Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hyaluronic Acid for Prevention of Post-Intubation Sore Throat and Hoarseness

NCT: NCT07040631 · COMPLETED

NCT IDNCT07040631
StatusCOMPLETED
Start Date2025-08-06
Completion2026-04-30
SponsorPusan National University Yangsan Hospital (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to find out whether applying Endotra Gel, a hyaluronic acid-based gel, to the endotracheal tube can help reduce sore throat and hoarseness after surgery. These symptoms are common after general anesthesia when a endotracheal tube is placed into the trachea. They can cause discomfort and affect patient recovery. The main questions this study aims to answer are: * Does Endotra Gel reduce the chance of having a sore throat after surgery? * Does it help improve hoarseness or coughing after surgery? Participants in this study will: * Undergo general anesthesia for breast cancer surgery * Be randomly assigned to one of two groups: * One group will receive Endotra Gel applied to the endotracheal tube before intubation * The other group will have standard care with no gel * Be monitored for sore throat, hoarseness, and coughing right after surgery and on the day after surgery * Answer questions about their symptoms and satisfaction with their recovery The results will help researchers learn whether using Endotra Gel during intubation can improve patient comfort and reduce airway irritation after surgery.

Frequently Asked Questions

What is Hyaluronic Acid for Prevention of Post-Intubation Sore Throat and Hoarseness?

Hyaluronic Acid for Prevention of Post-Intubation Sore Throat and Hoarseness is a clinical trial registered under NCT07040631. Current status: COMPLETED.

What is the status of NCT07040631?

The current status of NCT07040631 (Hyaluronic Acid for Prevention of Post-Intubation Sore Throat and Hoarseness) is: COMPLETED.

When did Hyaluronic Acid for Prevention of Post-Intubation Sore Throat and Hoarseness start?

Hyaluronic Acid for Prevention of Post-Intubation Sore Throat and Hoarseness started on 2025-08-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.